glucagon like peptide 1 glp 1 receptor agonist medications GLP-1 for Weight Loss and Diabetes Diagram of how GLP-1 glucagon-like
Description
Conclusion: This meta-analysis demonstrates that GLP-1 receptor agonists are a promising therapeutic option for patients with IIH, demonstrating significant efficacy in reducing intracranial pressure-related symptoms such as BMI, headache frequency, papilledema, and visual disturbances
To learn more about ag and food research in Arkansas, visit aaes.uada.edu
PMC 4020673
Eur J Heart Fail
Furthermore, the SGLT2-i hybrid diuretic effect, which combines natriuresis and osmotic diuresis, might also have cardioprotective properties leading to preload and myocardial stretch reduction (the diuretic hypothesis) (51)
